What is M2i Life Sciences?
M2i Life Sciences operates at the intersection of green chemistry and agricultural technology, specializing in the development of biocontrol solutions for both plant and animal health. The company utilizes sophisticated micro-encapsulation techniques and proprietary molecular research to create effective, non-toxic pest management systems. With a global footprint and a strong emphasis on research and development, M2i has established itself as a leader in the transition toward sustainable farming practices. Their business model integrates a comprehensive product catalog with collaborative partnerships, allowing them to address complex agricultural challenges while maintaining high standards of environmental safety and regulatory compliance.
How much funding has M2i Life Sciences raised?
M2i Life Sciences has raised a total of $13.5M across 1 funding round:
Private Equity
$13.5M
Private Equity (2017): $13.5M with participation from Idinvest Partners
Key Investors in M2i Life Sciences
Idinvest Partners
Idinvest Partners is a prominent mid-market private equity firm based in Paris, specializing in financing and supporting entrepreneurs across various stages of business development.
What's next for M2i Life Sciences?
With the support of its recent capital injection, M2i Life Sciences is well-positioned to accelerate its international expansion and deepen its R&D capabilities. The company is expected to focus on scaling its manufacturing infrastructure to meet the rising global demand for sustainable crop protection. By prioritizing the commercialization of its micro-encapsulation portfolio, M2i aims to capture a larger share of the biocontrol market, effectively bridging the gap between laboratory innovation and large-scale agricultural application. Future strategic initiatives will likely involve strengthening supply chain resilience and fostering new alliances to further integrate their solutions into mainstream agricultural workflows.
See full M2i Life Sciences company page
